| 摘要 |
The present invention provides a screening means for a novel therapeutic drug for arteriosclerosis capable of suppressing the progression of arteriosclerosis due to infection with Chlamydia pneumoniae. Specifically, provided is a screening method for a therapeutic substance for arteriosclerosis and/or a prophylactic/therapeutic substance for complications thereof, which comprises using cells of an established monocytic cell line and a Chlamydia pneumoniae-derived 60-kDa heat shock protein or a partial peptide thereof or a salt thereof or calls capable of producing the same (the cells may be identical to, or different from, the cells of the established monocytic cell line).
|
